Xinrui Li

1.8k citations
59 papers · 1.3k indexed · 1 hit paper · h-index 18
Topics
Lipoproteins and Cardiovascular Health (6 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers)Facial Rejuvenation and Surgery Techniques (4 papers)

In The Last Decade

Xinrui Li

55 papers receiving 1.3k citations

Hit Papers

Comparative efficacy of 11 non-pharmacological interventi...20222026202320242022255075

Peers

Xinrui Li
Comparison fields: 5 of 146
  • Molecular Biology 318
  • Immunology 221
  • Surgery 221
  • Epidemiology 146
  • Cardiology and Cardiovascular Medicine 140
Replace Negin Parsamanesh with:
Negin Parsamanesh Iran
Miaomiao Wang China
Bin Zhao China
Mohammad Najafi Iran
Meng Xu China
Qinghua Wu China
Yi‐Wen Huang China
Victoria McGilligan United Kingdom
Wang China
Sisi Yang China
Xinrui Li relative to Negin Parsamanesh Iran Negin Parsamanesh's profile →
Citations per field
00.5×10×20×30×40×45×
Negin Parsamanesh · 1×
Citations per year

Countries citing papers authored by Xinrui Li

Since Specialization
Citations

This map shows the geographic impact of Xinrui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinrui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinrui Li more than expected).

Fields of papers citing papers by Xinrui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinrui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinrui Li. The network helps show where Xinrui Li may publish in the future.

Co-authorship network of co-authors of Xinrui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xinrui Li. A scholar is included among the top collaborators of Xinrui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinrui Li. Xinrui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 4
4 12
5 0
6 3
7 6
8 5
9 94
10 8
11 7
12 55
13 253
14 11
15 21
16 27
17 47
18 17
19 41
20 18

About Xinrui Li

Xinrui Li is a scholar working on Cardiology and Cardiovascular Medicine, Dermatology and Surgery, having authored 59 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers) and Facial Rejuvenation and Surgery Techniques (4 papers). The work is most often cited by research in Immunology (221 citations), Endocrinology, Diabetes and Metabolism (123 citations) and Biochemistry (38 citations). Xinrui Li has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Shanshan Liu, Yifan Zhang, Yue Lu, Dekai Zhang, Wenhua Ling, Robert P. Kimberly, Min Xia, Dongfang Su, Ding Ding and Jian Qiu. Their work appears in journals such as Journal of the American Chemical Society, Circulation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026